EH

European Heart Journal

European Heart Journal is a leading cardiology journal publishing high-impact cardiovascular research, clinical guidelines, consensus statements, and reflective commentary, with strong global visibility, rigorous peer review, simple submission processes, and a prestigious author community.

Looking to publish in European Heart Journal? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Impact Factor 35.6
Quartile Q1
Open Access Type Hybrid
ISSN 0195-668X
eISSN 1522-9645
Invitation Only No
Cost Range Open access publication requires payment of an open access charge

Submission Instructions

European Heart Journal accepts the following article types. Click on an article type to view submission instructions.

Clinical Research Article

Cover Letter A cover letter is only specifically required when applying for Fast Track status and must explain the manuscript’s suitability for Fast Track.
Abstract A structured graphical abstract is required, consisting of text elements (Key Question, Key Finding, Take-home Message, up to 40 words each) plus a graphic element prepared to the journal’s specifications.
Manuscript Clinical Research Articles must not exceed 5,000 words, excluding the title, abstracts, legends, and references.
References References must follow Vancouver style, numbered in order of citation using Arabic numerals and listed with complete information and MEDLINE journal abbreviations where applicable; limit: 100 references.
Figures & Tables Any number of figures and tables is allowed, with no more than six panels per figure; supplementary material and videos are permitted.
Reformat to European Heart Journal using Livewrite Premium

Translational Science Article

Cover Letter A cover letter is only specifically required when applying for Fast Track status, where it must explain the manuscript’s suitability for Fast Track.
Abstract Translational Science Articles must also include a Translational Perspective of no more than 100 words, without references or abbreviations.
Manuscript Translational Science Articles must not exceed 5,000 words, excluding the title, abstracts, legends, and references.
References Translational Science Articles may include up to 100 references.
Figures & Tables Translational Science Articles may include any number of figures, tables, and videos, with no more than six panels per figure, as well as supplementary material.
Reformat to European Heart Journal using Livewrite Premium

Meta-analysis

Cover Letter A cover letter is specifically required only when applying for Fast Track status and must explain the manuscript’s suitability for Fast Track.
Abstract Meta-analyses must also include a Structured Graphical Abstract with Key Question, Key Finding, and Take-home Message (up to 40 words each) plus a graphic element prepared to the journal’s technical specifications.
Manuscript Meta-analyses must not exceed 5,000 words, excluding the title, abstracts, legends, and references.
References References must follow Vancouver style, numbered in order of citation with Arabic numerals and listed with complete information and MEDLINE journal abbreviations where applicable; Meta-analyses are limited to 100 references.
Figures & Tables Meta-analyses may include any number of figures, tables, and videos, with no more than six panels per figure, and may also include supplementary material.
Reformat to European Heart Journal using Livewrite Premium

State of the Art Review

Cover Letter No specific cover letter requirements are specified, including whether a cover letter is required.
Abstract A text abstract is required, unstructured, must not exceed 250 words, and must not contain references or abbreviations; a separate graphical abstract is also required.
Manuscript State of the Art Reviews must not exceed 5,000 words, excluding the title, abstracts, legends, and references, and must include a text abstract, graphical abstract, and up to six keywords, with no specific section structure otherwise specified.
References References must follow Vancouver style (numbered in order of citation with MEDLINE journal abbreviations) and are limited to a maximum of 150 references.
Figures & Tables Figures, tables, and supplementary files must be uploaded as separate files with approximate positions indicated in the manuscript; any number of figures, tables, and videos is allowed, with no more than six panels per figure.
Reformat to European Heart Journal using Livewrite Premium

Editorial

Cover Letter No specific cover letter requirements are specified for Editorials.
Abstract No abstract is specified or required for Editorials.
Manuscript Editorials must not exceed 1,500 words, excluding the title, legends, and references, and must not have more than three authors; they must include a graphical abstract and must not include figures, tables, videos, keywords, or supplementary material.
References References must be formatted in Vancouver style, numbered in order of citation with Arabic numerals and MEDLINE journal abbreviations where applicable; limit: 15 references for Editorials.
Figures & Tables Editorials must not include figures, tables, videos, or supplementary material, and graphical abstracts must be uploaded as separate files with their position indicated in the manuscript.
Reformat to European Heart Journal using Livewrite Premium

Recent Publications

Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis

Hiddo J L Heerspink, Jelle M Beernink, Rajiv Agarwal, David Z I Cherney, Carolyn S P Lam, Brendon L Neuen, Vlado Perkovic, Katherine R Tuttle, Pantelis Sarafidis, Rita Birne, Xiangmei Chen, Mads Hornum, Rafael A Maldonado, Masaomi Nangaku, Susanne B Nicholas, Atsuki Ohashi, Pablo E Pergola, See Cheng Yeo, Niels Jongs, J David Smeijer, Carolina Aldworth, Meike Brinker, Peter Kolkhof, Juliana D Reis, Andrea Scalise, Christoph Wanner

10.1093/eurheartj/ehag729
View Publication

Local vs systemic inflammation and outcomes after percutaneous coronary intervention

Zixiang Ye, Enmin Xie, Chenyue Liu, Hao-Yu Wang, Chenxi Song, Rui Zhang, Shanshan Shi, Kefei Dou

10.1093/eurheartj/ehag731
View Publication

One vs twelve month aspirin after percutaneous coronary intervention for acute myocardial infarction: individual patient-data analysis of TARGET-FIRST and ULTIMATE-DAPT trials

Giuseppe Tarantini, Xiaojuan Zhang, Luca Nai Fovino, Jing Kan, Zhen Ge, Guillaume Cayla, Pieter C Smits, Benjamin Honton, Valeria Paradies, Yann Poezevara, David Bouchez, Xiaofei Gao, Bilal S Mohydin, Fentang Gao, Yibing Shao, Xiang Chen, Gregg W Stone, Shao-Liang Chen

10.1093/eurheartj/ehag737
View Publication

Development and external validation of the SCORE2 models in Latin America and the Caribbean (SCORE2-LAC) to estimate 10-year cardiovascular disease risk

Stella Bijkerk, Carlos I Ponte-Negretti, Ko Ko Maung, Louisa Gnatiuc Friedrichs, Jesús Alegre-Díaz, Simon G Anderson, Claudia Bambs, Mauricio L Barreto, Antonio Bernabe-Ortiz, Stefan Blankenberg, Alfredo Cabrera-Villamizar, Rodrigo M Carrillo-Larco, Luis F S Castro-de-Araujo, William Checkley, Sandra Cortés, Jannick A N Dorresteijn, Walter G Espeche, Catterina Ferreccio, Patrícia Fortes C. de Macêdo, Oscar H Franco, Sergio Gimenez, Gonzalo C Grazioli, Christina Howitt, Vilma E Irazola, Stephen Kaptoge, Pablo Kuri-Morales, Fernando Lanas, Bernardo Layerle, José P Lopez-Lopez, Thiess Lorenz, Paulo A Lotufo, Claudia Marco, J Jaime Miranda, Carolina Nazzal, José Ortellado, Julia M Pescarini, Franco Peverelli, Alejandro Pomi, Luiz E Ritt, Carlos Daniel Rodríguez-Ariza, Martín Salazar, Carlos A Sánchez-Vallejo, Pamela Seron, Itamar de Souza Santos, Roberto Tapia-Conyer, Pedro Zitko, Emanuele Di Angelantonio, Pedro M Marques-Vidal, Ana M Abreu, Frank L J Visseren, Steven H J Hageman, Maryam Kavousi, John William McEvoy, Angela M Wood, Ana Múnera, Vladimir Ullauri, Osiris Valdez Tiburicio, Fernando Wyss

10.1093/eurheartj/ehag698
View Publication

ESC Guidelines on prevention and rehabilitation in coronary heart disease and current practice: the EUROASPIRE VI survey

David A Wood, Catriona S Jennings, Kornelia Kotseva, Agnieszka Adamska, Iris Erlund, Sandra Ganly, Per-Henrik Groop, Susan Hennessy, Maarten J G Leening, Linda Mellbin, Kausik K Ray, Lars Ryden, Terhi Vihervaara, Victor Aboyans, Ana Abreu, Carlos Aguiar, Karl Andersen, Jolita Badariene, Jan Bruthans, Monika Burzynska, Almudena Castro Conde, Renata Cifkova, Furio Colivicchi, Kairat Davletov, Mirza Dilic, Elena Dimitrova, Maryna Dolzhenko, Vilnis Dzerve, Andrejs Erglis, Zlatko Fras, Baris Gungor, Peter Heuschmann, Piotr Jankowski, Iulia Kulcsar, Nebojsa M Lalic, Seppo Lehto, Dragan Lovic, Aldo P Maggioni, Fabrice MAC Martens, Lampros K Michalis, Davor Milicic, Erkin Mirrakhimov, Greg Murphy, Oner Ozdogan, Jurgita Plisiene, Zeljko Reiner, Stefan Stoerk, Lale Tokgozoglu, Jamol Uzokov, Dusko Vulic, Dirk De Bacquer, John W McEvoy

10.1093/eurheartj/ehag741
View Publication

Frequently asked questions

How long does it take to publish?

Fast Track manuscripts receive an initial decision within 7 working days, and Fast Track articles are typically published in their final version within 10 working days after acceptance, subject to timely completion of licensing and proof corrections.

Reformat to European Heart Journal using Livewrite Premium

Is a cover letter required?

A cover letter is required when applying for Fast Track status and should explain why the manuscript is suitable for expedited review; authors may also use the cover letter to request exclusion of specific reviewers or to note if an editor is a co-author or contributor.

Reformat to European Heart Journal using Livewrite Premium

What are the publication costs?

There is no charge to publish under a standard licence, while open access publication is subject to an open access charge, which may be covered under eligible institutional Read and Publish agreements.

Reformat to European Heart Journal using Livewrite Premium

Research Topics

Cardiac Imaging and Diagnostics Cardiovascular Function and Risk Factors Atrial Fibrillation Management and Outcomes Cardiac Valve Diseases and Treatments Cardiac Arrhythmias and Treatments